Atlas Trials

A Relative Bioavailability Study of Valcyte (Valganciclovir) in Lung Transplant Recipients With or Without Cystic Fibrosis.

Clinical trial NCT00377741 · COMPLETED

Trial details

NCT number
NCT00377741
Sponsor
Hoffmann-La Roche
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Cytomegalovirus Infections
Start date
2004-12-01
Primary completion
2006-06-01
Enrollment
31

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.